Attenuation and efficacy of human parainfluenza virus type 1 (HPIV1) vaccine candidates containing stabilized mutations in the P/C and L genes

BACKGROUND: Two recombinant, live attenuated human parainfluenza virus type 1 (rHPIV1) mutant viruses have been developed, using a reverse genetics system, for evaluation as potential intranasal vaccine candidates. These rHPIV1 vaccine candidates have two non-temperature sensitive (non-ts) attenuati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartlett, Emmalene J, Castaño, Adam, Surman, Sonja R, Collins, Peter L, Skiadopoulos, Mario H, Murphy, Brian R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939843/
https://www.ncbi.nlm.nih.gov/pubmed/17605811
http://dx.doi.org/10.1186/1743-422X-4-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939843/
https://www.ncbi.nlm.nih.gov/pubmed/17605811
http://dx.doi.org/10.1186/1743-422X-4-67

Ejemplares similares